Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma

BACKGROUND: Although both the SHARP and the Asian-Pacific trials showed improved overall survival (OS) for sorafenib, the magnitude of benefit was substantially less for Asians, who have a higher prevalence of hepatitis B viral (HBV) infection. Whether the worse prognosis is related to ethnicity or...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Peixoto, Renata D’Alpino, Renouf, Daniel J., Gill, Sharlene, Cheung, Winson Y., Lim, Howard J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110502/
https://ncbi.nlm.nih.gov/pubmed/25083298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.036
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak